According to study, “Global Organic Pharmaceutical Excipients Market Size study, by Product (Oleo Chemicals, Carbohydrates, Petrochemicals, Protein, Others), by Application (Oral Formulation, Topical Formulation, Parenteral Formulation, Others) and Regional Forecasts 2018-2025” some of the major companies that are currently working in the global organic pharmaceutical excipients market are DowDuPont, BASF SE, Roquette Group, Evonik Industries AG, Ashland Inc., Berkshire Hathaway Inc., Kerry, Croda International Plc, Associated British Foods Inc., P & G Chemicals, Akzo Nobel NV, Lubrizol Corp., FMC Corp., Ferro Corp., Cargill Inc., Eastman Chemical Company, The Dow Chemical Company, Archer Daniels Midland Company (Adm), Royal Dutch Shell Plc., Innophos Holdings, Signet, Wacker Chemie.
Pharmaceutical excipients are the inactive matter or substance formulating absolute drug dosage forms. Excipients help in improving the bioavailability of pharmaceutical ingredient pharmaceutical. It also helps in overall protection and efficiency of the formulation during its storage. Some of the ideal characteristics include nontoxic, non-reactive, chemically stable, inert to human body, low equipment & process sensitive and economical.
Based on product, the organic pharmaceutical excipients market is segmented into carbohydrates, protein, oleo chemicals, petrochemicals, acrylic polymers, mineral hydrocarbons and others. Carbohydrate is further sub-segmented into cellulose (cellulose ethers, cellulose esters, microcrystalline cellulose and cmc & croscarmellose sodium), sugars (mannitol, sorbitol, lactose, sucrose, dextrose) and starch (dried starch, modified starch and converted starch). Oleochemical is further sub-segmented into mineral stearates, fatty alcohols, glycerin and others. A petrochemical includes providones, acrylic polymers, glycols, mineral hydrocarbons (mineral waxes, petrolatum, and mineral oils) and others.
Based on functionality, market is segmented into binders, preservatives, disintegrants, fillers & diluents, coating agents, colorants, emulsifying agents, lubricants & glidants, suspending & viscosity agents, flavoring agents & sweeteners and other functionalities. Based on the type of formulation, the market is defined as oral formulations, parenteral formulations and topical formulations. Oral formulation includes capsules (soft gelatin capsules & hard gelatin capsules), tablets and liquid formulations.
The global organic pharmaceutical excipients market is driven by growing demand of pharmaceutical excipients owing to the rising aging population. Some other driven aspects include rising demands of generics, rapid growth in biopharmaceutical sector, advancement in functional excipient development and incidence of chronic diseases. However, some of the limiting factors include lengthy FDA process, safety & quality concerns and rising regulatory stringency. In addition, the growth in the biosimilars market and shifting focus of pharmaceutical manufacturing to emerging countries are few opportunities for the market. Moreover, improving excipient capabilities by using nanotechnology, rising demand & emphasis on co-processed excipients and increasing use of direct compression in oral dosage formulations are some new industrial trends of market.
North American region accounts for the foremost share due to boost in the key market players in the province. Europe is too contributing highest share in the market. It is expected that the Asia-Pacific region to grow fast due to the expansion of owing to large investment made in the countries such as India and China. In near future, it is predicted that the global organic pharmaceutical excipients market to grow rapidly owing to increase in incidence of chronic diseases.
To know more, click on the link below:
Ankur Gupta, Head Marketing & Communications